T1	Eq-Comparison 42 52	6-12 years
E1	Eq-Comparison:T1 Value:T70 Operator:T71 Value:T72 Temporal-Unit:T73
T2	Temporal-Connection 75 80	After
E2	Temporal-Connection:T2
A1	Temporal-Connection-Type-Value E2 after
T3	Birth 81 86	birth
E3	Birth:T3
T4	Eq-Comparison 88 93	three
E4	Eq-Comparison:T4
T5	Procedure 94 104	injections
E5	Procedure:T5 Name:T74
T6	Drug 108 113	Hep B
E6	Drug:T6 Name:T75
T7	Observation 119 137	inoculated in time
E7	Observation:T7
T8	Procedure 155 164	procedure
E8	Procedure:T8
T9	Eq-Comparison 168 178	0, 1 and 6
E9	Eq-Comparison:T9 Value:T76 Value:T77
T10	Negation 227 229	No
E10	Negation:T10
T11	Drug 230 249	HBV booster vaccine
E11	Drug:T11 Name:T78
T12	Eq-Comparison 256 261	since
E12	Eq-Comparison:T12
T13	Procedure 270 286	HBV immunization
E13	Procedure:T13
T14	Or 301 303	or
E14	Or:T14
T15	Study 343 348	study
E15	Study:T15
T16	Study 366 371	study
E16	Study:T16
T17	Temporal-Connection 393 398	after
E17	Temporal-Connection:T17
A2	Temporal-Connection-Type-Value E17 after
T18	Assertion 411 417	can be
E18	Assertion:T18
A3	Assertion-Type-Value E18 hypothetical
T19	Eq-Comparison 529 536	history
E19	Eq-Comparison:T19 Temporal-Period:T81
T20	Allergy 540 547	allergy
E20	Allergy:T20
T21	Or 548 550	or
E21	Or:T21
T22	Procedure 570 586	vaccine reaction
E22	Procedure:T22
T23	Condition 597 623	immune impairment diseases
E23	Condition:T23 Name:T83
T24	Or 624 627	and
E24	Or:T24
T25	Modifier 628 634	appear
E25	Modifier:T25
T26	Condition 635 652	immune impairment
E26	Condition:T26 Name:T84
T27	Drug 659 676	Immunosuppressive
E27	Drug:T27 Name:T85
T28	Procedure 677 686	treatment
E28	Procedure:T28
T29	Assertion 688 699	receive any
E29	Assertion:T29
A4	Assertion-Type-Value E29 hypothetical
T30	Procedure 700 709	injection
E30	Procedure:T30 Name:T86
T31	Or 710 712	or
E31	Or:T31
T32	Procedure 713 732	oral administration
E32	Procedure:T32
T33	Drug 736 745	cortisone
E33	Drug:T33 Name:T88
T34	Or 746 748	or
E34	Or:T34
T35	Condition 749 755	cancer
E35	Condition:T35 Name:T89
T36	Procedure 756 768	chemotherapy
E36	Procedure:T36 Name:T90
T37	Drug 787 794	vaccine
E37	Drug:T37
T38	Or 795 797	or
E38	Or:T38
T39	Study 810 821	observation
E39	Study:T39
T40	Drug 822 826	drug
E40	Drug:T40
T41	Condition 836 846	vaccinated
E41	Condition:T41 Name:T91
T42	Eq-Comparison 854 869	past four weeks
E42	Eq-Comparison:T42 Temporal-Period:T92 Value:T93 Temporal-Unit:T94
T43	Condition 880 893	acute disease
E43	Condition:T43 Name:T96
T44	Or 894 896	or
E44	Or:T44
T45	Other 897 902	other
E45	Other:T45
T46	Condition 903 912	infection
E46	Condition:T46 Name:T97
T47	Assertion 913 922	requiring
E47	Assertion:T47
A5	Assertion-Type-Value E47 hypothetical
T48	Drug 923 933	antibiotic
E48	Drug:T48 Name:T98
T49	Or 934 936	or
E49	Or:T49
T50	Drug 937 946	antiviral
E50	Drug:T50 Name:T99
T51	Procedure 947 956	treatment
E51	Procedure:T51
T52	Eq-Comparison 964 979	past four weeks
E52	Eq-Comparison:T52 Temporal-Period:T100 Value:T101 Temporal-Unit:T102
T53	Condition 986 991	Fever
E53	Condition:T53 Name:T103
T54	Assertion 992 1000	symptoms
E54	Assertion:T54
A6	Assertion-Type-Value E54 possible
T55	Eq-Comparison 1017 1026	past week
E55	Eq-Comparison:T55 Temporal-Period:T104 Temporal-Unit:T105
T56	Observation 1029 1049	axillary temperature
E56	Observation:T56
T57	Eq-Comparison 1050 1056	≥ 38 ℃
E57	Eq-Comparison:T57 Operator:T106 Value:T107 Unit:T108
T58	Eq-Comparison 1105 1112	history
E58	Eq-Comparison:T58 Temporal-Period:T110
T59	Condition 1129 1148	infectious diseases
E59	Condition:T59 Name:T112
T60	Eq-Comparison 1151 1155	five
E60	Eq-Comparison:T60
T61	Condition 1165 1174	hepatitis
E61	Condition:T61 Name:T113
T62	Condition 1176 1180	AIDS
E62	Condition:T62 Name:T114
T63	Condition 1182 1190	syphilis
E63	Condition:T63 Name:T115
T64	Condition 1192 1201	gonorrhea
E64	Condition:T64 Name:T116
T65	Condition 1216 1237	Hepatitis B infection
E65	Condition:T65 Name:T117
T66	Or 1238 1240	or
E66	Or:T66
T67	Condition 1241 1269	carriers(lineal relationship
E67	Condition:T67 Name:T118
T68	Procedure 1286 1306	physical examination
E68	Procedure:T68 Name:T119
T69	Life-Stage-And-Gender 25 33	Children
A7	Life-Stage-And-Gender-Type T69 child
T70	Eq-Value 42 43	6
T71	Eq-Operator 43 44	-
A8	Eq-Operator-Value T71 BETWEEN
T72	Eq-Value 44 46	12
T73	Eq-Temporal-Unit 47 52	years
A9	Eq-Temporal-Unit-Value T73 year
T74	Procedure-Name 94 104	injections
T75	Drug-Name 108 111	Hep
T76	Eq-Value 171 172	1
T77	Eq-Value 177 178	6
T78	Drug-Name 230 249	HBV booster vaccine
T79	Life-Stage-And-Gender 292 300	Children
A10	Life-Stage-And-Gender-Type T79 child
T80	Observation-Specimen 376 381	blood
T81	Eq-Temporal-Period 529 536	history
A11	Eq-Temporal-Period-Value T81 past
T82	Severity 562 569	serious
A12	Severity-Value T82 severe
T83	Condition-Name 597 623	immune impairment diseases
T84	Condition-Name 635 652	immune impairment
T85	Drug-Name 659 676	Immunosuppressive
T86	Procedure-Name 700 709	injection
T87	Drug-Name 713 732	oral administration
T88	Drug-Name 736 745	cortisone
T89	Condition-Name 749 755	cancer
T90	Procedure-Name 756 768	chemotherapy
T91	Condition-Name 836 846	vaccinated
T92	Eq-Temporal-Period 854 858	past
A13	Eq-Temporal-Period-Value T92 past
T93	Eq-Value 859 863	four
T94	Eq-Temporal-Unit 864 869	weeks
A14	Eq-Temporal-Unit-Value T94 week
T95	Severity 880 885	acute
A15	Severity-Value T95 severe
T96	Condition-Name 886 893	disease
T97	Condition-Name 903 912	infection
T98	Drug-Name 923 933	antibiotic
T99	Drug-Name 937 946	antiviral
T100	Eq-Temporal-Period 964 968	past
A16	Eq-Temporal-Period-Value T100 past
T101	Eq-Value 969 973	four
T102	Eq-Temporal-Unit 974 979	weeks
A17	Eq-Temporal-Unit-Value T102 week
T103	Condition-Name 986 991	Fever
T104	Eq-Temporal-Period 1017 1021	past
A18	Eq-Temporal-Period-Value T104 past
T105	Eq-Temporal-Unit 1022 1026	week
A19	Eq-Temporal-Unit-Value T105 week
T106	Eq-Operator 1050 1051	≥
A20	Eq-Operator-Value T106 GTEQ
T107	Eq-Value 1052 1054	38
T108	Eq-Unit 1055 1056	℃
T109	Condition-Name 1064 1081	Blood transfusion
T110	Eq-Temporal-Period 1105 1112	history
A21	Eq-Temporal-Period-Value T110 past
T111	Severity 1121 1128	serious
A22	Severity-Value T111 severe
T112	Condition-Name 1129 1148	infectious diseases
T113	Condition-Name 1165 1174	hepatitis
T114	Condition-Name 1176 1180	AIDS
T115	Condition-Name 1182 1190	syphilis
T116	Condition-Name 1192 1201	gonorrhea
T117	Condition-Name 1216 1237	Hepatitis B infection
T118	Condition-Name 1241 1269	carriers(lineal relationship
T119	Procedure-Name 1286 1306	physical examination